Skip to main content
SCNX
NASDAQ Life Sciences

Scienture Q3 Revenue Jumps 113% to $1.25M as REZENOPY Launch Delivers $925K

Tom Rudovsky · Reported by Wiseek News
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.01
Mkt Cap
$4.763M
52W Low
$2.64
52W High
$18.75
52W Position info
14% above low
Off High info
84% below high
Rel. Volume
Market data snapshot near publication time

SCNX is trading near its 52-week low of $2.64 (14% above the low).

Summary

Scienture reported Q3 2026 revenue of $1.25M, up about 113% year over year and roughly 265% sequentially, confirming the preliminary ~$1.22M figure it released on October 13. The August launch of REZENOPY drove about $925K of net product revenue, with the rest coming from Arbli and related products. Gross profit was $1.02M, up about 77.5% year over year, so profit grew slower than sales. Nine-month revenue reached $1.65M, up about 176%. Management says it is targeting profitability in 2027, but that is an objective, not guidance, and the release flags dependence on wholesaler ordering patterns that can swing quarterly revenue. The company is still very small — this is an early commercial-stage story where repeat REZENOPY orders and broader distribution decide whether the growth holds.

Updates

  1. · SEC 8-K — Scienture's Q3 2026 gross margin was about 81.3%, and it held $7.8M in cash and restricted cash as of September 30, 2026.

At the time of this announcement, SCNX was trading at $3.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8M. The 52-week trading range was $2.64 to $18.75. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

SCNX - Latest Insights

SCNX
Nov 19, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.44
Real-time Price: $2.46 info
Change: +$0.025 (+1%) info
Market Cap: $4.354M info
SCNX
Oct 19, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.92
Real-time Price: $2.46 info
Change: -$0.460 (-16%) info
Market Cap: $4.354M info
SCNX
Oct 13, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.03
Real-time Price: $2.46 info
Change: -$1.57 (-39%) info
Market Cap: $4.354M info
SCNX
Oct 02, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.1864
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.354M info
SCNX
Sep 30, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.220
Real-time Price: $2.46 info
Change: Reverse Stock Split info
Market Cap: $4.354M info